Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |